Dr. Reddy`s Laboratories Other Current Liabilities

As of the most recent data (June 2026), RDY shows a other current liabilities of $54B. That compares with $49B in the prior-year period — up 9.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RDY's other current liabilities is now $54B (was $49B) — a 9.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dr. Reddy`s Laboratories is outperforming or lagging.

Tracking RDY's other current liabilities over time shows whether Dr. Reddy`s Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $54B That compares with $49B in the prior-year period — up 9.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Dr. Reddy`s Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $54B) with ownership activity and broader fundamentals.

Dr. Reddy`s Laboratories's other current liabilities is $54B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.